US Patent Number

4885287

Publication Date

12-5-1989

Abstract

The invention relates to a novel method of administering aspirin to achieve improved delivery thereof. The invention further relates to novel dosage forms of neutralized aspirin adapted for nasal administration, such as solutions, suspensions, gels and ointments. These dosage forms find utility in the treatment of conditions known to respond to the administration of aspirin, particularly in the treatment of migraine and in the mitigation of cardiovascular damage resulting from heart attack.

Assignees

University of Kentucky Research Foundation, Lexington, Ky.

Application Number

229,963

Filing Date

08/09/1988

Share

COinS